Peter Attia Longevity Protocol: What It Would Actually Cost a Non-Celebrity

Who Is Peter Attia and Why Does His Protocol Matter?

Peter Attia is a Stanford- and Johns Hopkins-trained surgeon who left clinical oncology to run a private longevity medicine practice. His 2023 book "Outlive: The Science and Art of Longevity" sold over one million copies within its first year and brought concepts like VO2max as a mortality predictor into mainstream health conversations.

His public disclosures are unusually detailed for a physician. On his podcast, The Drive, and in "Outlive," Attia names specific drugs, doses, and diagnostic tests he uses personally. That transparency makes his protocol unusually auditable, though it also carries caveats: he treats himself as a patient of one, and he has publicly reversed course on at least one major drug choice (metformin, which he stopped after data from the TAME trial and CGM experiments suggested it blunted training adaptations) [1].

Why Longevity Medicine Lacks Standard Guidelines

Longevity medicine sits outside any single specialty. The American College of Sports Medicine (ACSM) publishes exercise guidelines [2], the Endocrine Society covers hormone therapy [3], but no major body has issued a unified "longevity protocol" standard. Attia fills that vacuum for many patients, which is why understanding the evidence, and cost, behind his specific choices matters.

The "Four Horsemen" Framework

Attia organizes his practice around what he calls the four leading causes of death in developed countries: cardiovascular disease, cancer, neurodegenerative disease, and metabolic dysfunction. His protocol targets all four simultaneously. That framing is consistent with CDC mortality data showing heart disease and cancer account for roughly 45% of all US deaths annually [4].

The Exercise Foundation: Highest Evidence, Lowest Cost

Exercise is where the evidence is strongest and the cost is lowest. Attia describes spending approximately 10 to 12 hours per week on structured physical activity, split between Zone 2 aerobic work, VO2max intervals, and resistance training.

Zone 2 Cardio

Zone 2 training means working at an intensity where you can hold a conversation but are clearly breathing harder than at rest. Metabolically, it corresponds to roughly 60 to 75% of maximum heart rate or a lactate level below 2 mmol/L.

A 2022 meta-analysis in the British Journal of Sports Medicine (N=196 studies, over 30 million person-years) found that 150 to 300 minutes per week of moderate-intensity aerobic activity was associated with a 19% reduction in all-cause mortality compared to no activity [5]. Attia targets the upper end of that range.

Cost: Zero to $50/month for a gym membership or outdoor running shoes. A heart rate monitor capable of Zone 2 tracking runs $30 to $150 (Polar H10, Garmin).

VO2max as a Longevity Biomarker

VO2max is the single laboratory measure Attia cites most often as a longevity predictor. A 2018 JAMA Network Open study of 122,007 patients found that low cardiorespiratory fitness carried a higher adjusted mortality hazard ratio than smoking, hypertension, or diabetes [6]. Patients in the top 2.5% of VO2max for their age had roughly 5 times lower all-cause mortality risk than those in the bottom 25%.

A formal VO2max test at a sports medicine lab costs $150 to $350. Attia recommends retesting annually.

Resistance Training

Attia emphasizes grip strength and leg strength as functional longevity markers, citing data that low grip strength predicts cardiovascular mortality independently of other risk factors [7]. He trains three times per week with compound lifts.

Gym membership: $20 to $80/month. A home barbell setup: $500 to $1,500 one-time.

Diagnostics: What Attia Tests and What It Costs

Attia's diagnostic panel is broader and more frequent than standard preventive care. Most of these tests are not covered by insurance when ordered without a specific disease diagnosis.

Lipid and Metabolic Panel

Beyond a standard lipid panel, Attia orders ApoB (apolipoprotein B) rather than LDL-C as his primary atherogenic particle count. He also tracks Lp(a) at baseline. A 2022 European Heart Journal consensus statement identified ApoB as a superior predictor of cardiovascular risk compared to LDL-C [8].

• Standard lipid panel (often covered): $0 to $30 with insurance
• ApoB (cash pay): $25 to $60
• Lp(a) (cash pay, once in a lifetime per most guidelines): $30 to $80
• hsCRP: $15 to $40
• Fasting insulin: $20 to $50

Advanced Body Composition (DEXA)

Attia uses DEXA scans to track lean mass and visceral fat, not just weight. A DEXA scan at a dedicated body-composition center costs $40 to $75. Attia appears to scan at least annually.

Continuous Glucose Monitor (CGM)

Attia used a CGM for an extended period to characterize his personal glycemic response to foods and exercise. He no longer wears one continuously but recommends periodic 2-week CGM "experiments" for metabolically healthy people.

The Dexacom Stelo and Abbott Lingo are now FDA-cleared over-the-counter CGMs for non-diabetic users [9]. A two-week sensor costs approximately $49 to $99. A 28-day experiment (two sensors): $100 to $200.

Cognitive and Cancer Screening

Attia advocates for earlier and more frequent cancer screening than standard guidelines, including coronary artery calcium (CAC) scoring for cardiovascular risk stratification. A CAC scan at an imaging center runs $75 to $200 cash pay. APOE genotyping (Alzheimer's risk) costs $200 to $400 through a clinical lab.

The Pharmacology Stack: Rx Drugs Attia Has Disclosed

This section covers only drugs Attia has discussed publicly and on the record. Doses and regimens are drawn from his podcast statements and "Outlive." This is not a prescription recommendation.

Rapamycin (Sirolimus)

Rapamycin is the most discussed drug in Attia's protocol. It is an mTOR inhibitor originally approved by the FDA for organ transplant rejection prevention [10]. In longevity circles, it is used off-label at low weekly doses based on preclinical data showing lifespan extension in multiple species.

The landmark Interventions Testing Program study published in 2009 found that rapamycin extended median lifespan in genetically heterogeneous mice by 9 to 14% even when initiated late in life [11]. Attia has stated publicly he takes approximately 5 to 6 mg once weekly, though he has varied this dose over time.

Human randomized controlled trial data in healthy adults is limited. The PEARL trial tested 5 mg weekly rapamycin vs. Placebo in older adults; results for some immune and biomarker endpoints were published in 2023 [12]. The drug is not FDA-approved for longevity use, and prescribing it off-label requires a physician willing to accept that clinical and legal context.

Cost: Rapamycin 1 mg tablets at compounding pharmacies run approximately $1 to $3 per mg. At 5 mg/week, that is $260 to $780/year for the drug alone. A prescribing physician's consultation adds $200 to $500 for the initial visit.

Metformin (Discontinued by Attia)

Attia took metformin for several years and then stopped. He has explained publicly that CGM data and a 2022 paper in Nature Aging [13] suggested metformin attenuated the VO2max and muscle hypertrophy gains from exercise, an unacceptable tradeoff for someone prioritizing fitness-based longevity.

Metformin 500 to 1,000 mg/day is extremely cheap: roughly $4 to $12/month at generic pricing. The TAME (Targeting Aging with Metformin) trial is ongoing and will provide the first prospective human longevity data [1].

Low-Dose Naltrexone (LDN)

Attia has mentioned LDN at 1.5 to 4.5 mg nightly in the context of immune modulation, though he is more cautious about this than rapamycin. The evidence base in healthy adults is thin. Compounded LDN costs $30 to $60/month.

Testosterone Replacement Therapy (TRT)

Attia has discussed his own testosterone use and has been transparent that his testosterone was below reference range before starting therapy. The Endocrine Society's 2018 guidelines recommend TRT for men with symptomatic hypogonadism and confirmed low testosterone on two morning measurements [3]. Testosterone is not a longevity drug per se, but maintaining muscle mass and bone density as testosterone declines with age has clear functional implications.

Cost: Generic testosterone cypionate injection: $30 to $80 for a 10 mL vial (200 mg/mL) at most pharmacies. Testosterone gel (e.g., AndroGel 1.62%): $300 to $600/month brand, $30 to $80/month generic. With telehealth providers, total monthly cost including physician oversight runs $99 to $199.

Thyroid and Other Hormones

Attia has discussed thyroid optimization and DHEA in various podcast episodes, but his current personal use of these is less clearly documented. Thyroid testing (TSH, free T4, free T3) costs $30 to $100 cash pay.

Sleep: The Zero-Cost Intervention With the Highest ROI

Attia calls sleep the "greatest legal performance-enhancing drug" and cites Matthew Walker's work as well as his own use of an Oura Ring for sleep tracking. A 2019 review in Science advances showed that chronic sleep restriction to 6 hours per night produced cognitive deficits equivalent to two full nights of sleep deprivation [14].

Attia targets 8 to 8.5 hours of sleep per night, with a consistent bedtime and wake time. He uses a cold sleep environment (approximately 67 to 68 degrees Fahrenheit) and avoids alcohol completely, citing data that even moderate alcohol disrupts deep and REM sleep architecture [15].

Cost breakdown:

• Oura Ring Gen3: $299 to $349 one-time plus $5.99/month subscription
• Cool sleep environment (fan or mattress pad): $30 to $300
• Sleep hygiene protocol: free

Nutrition: Protein Targeting and Time-Restricted Eating

Attia's nutritional approach has evolved. He previously practiced extended fasting and ketogenic diets and has since publicly moderated both positions. His current focus is on adequate protein intake (he targets 1 gram per pound of body weight per day) and limiting ultra-processed foods.

A 2022 study in Cell Metabolism (N=21 adults) found that ad libitum ultra-processed diets led to 500 kcal/day excess intake compared to unprocessed diets over two weeks [16]. That is not a longevity-specific trial, but it supports the practical recommendation to minimize processed food.

Protein targeting of 1.6 to 2.2 g/kg/day is consistent with a 2017 meta-analysis in the British Journal of Sports Medicine showing that protein supplementation significantly augmented muscle mass gains from resistance training up to approximately 1.62 g/kg/day [17]. Cost of hitting that target through whole foods varies, but a high-quality whey or casein protein supplement adds roughly $40 to $80/month if needed.

Supplements: What Attia Takes and What the Evidence Shows

Attia is relatively conservative about supplements compared to many longevity influencers. Publicly confirmed supplements include:

• Omega-3 fatty acids (EPA/DHA): He targets 2 to 4 g/day combined EPA plus DHA. A 2021 Cochrane review found omega-3 supplementation reduced cardiovascular mortality by approximately 7% and non-fatal MI by 13% in high-risk populations [18]. Cost: $20 to $50/month for pharmaceutical-grade fish oil.
• Vitamin D3 plus K2: Attia aims for a serum 25-OH vitamin D above 40 ng/mL. Supplementation with 2,000 to 4,000 IU D3 daily costs $5 to $15/month.
• Magnesium (glycinate or L-threonate): Primarily for sleep quality and neurological function. Cost: $15 to $30/month.
• Creatine monohydrate: 5 g/day for muscle and potentially cognitive function. A 2003 Cochrane review confirmed creatine augments strength gains from resistance training [19]. Cost: $10 to $20/month.

Mental and Emotional Health: The Component Attia Almost Missed

In "Outlive," Attia devotes a full section to what he calls the "Emotional Quadrant" and describes years of intensive psychotherapy, including a 6-week residential program. He argues that emotional health is inseparable from physical longevity, citing data on social isolation and mortality risk.

A 2015 meta-analysis in Perspectives on Psychological Science (N=3.4 million) found social isolation associated with a 29% increased mortality risk and loneliness associated with a 26% increase [20].

Ongoing individual therapy costs $100 to $300/session out of pocket. Group therapy or community-based approaches are significantly cheaper.

Full Cost Breakdown: Three Tiers

The following framework stratifies Attia's protocol by evidence strength and cost, giving a non-celebrity patient a prioritized entry point.

Tier 1, Essential (highest evidence, lowest cost): $1,200 to $3,000/year

| Element | Annual Cost | |---|---| | Zone 2 cardio (gym or outdoor) | $0, $600 | | Resistance training (gym) | $240, $960 | | Sleep hygiene (no tech) | $0 | | Whole-food high-protein diet | $0, $600 incremental | | Annual VO2max test | $200, $350 | | Annual blood panel (ApoB, hsCRP, fasting insulin, CBC) | $150, $300 | | Creatine, vitamin D3, magnesium | $360, $780 |

Tier 2, Enhanced (moderate evidence, moderate cost): adds $2,000 to $6,000/year

| Element | Annual Cost | |---|---| | Omega-3 (pharmaceutical grade) | $360, $600 | | DEXA scan (annual) | $60, $120 | | Two CGM experiments (28 days total) | $100, $200 | | CAC score | $75, $200 | | Oura Ring | $370 first year | | TRT (if hypogonadal, with physician) | $1,200, $2,400 | | Wearable HRV/sleep tracker ongoing | $120, $240 |

Tier 3, Full stack (off-label Rx, specialist oversight): adds $4,000 to $9,000/year

| Element | Annual Cost | |---|---| | Rapamycin 5 mg/week (compounded) | $260, $780 | | LDN (compounded) | $360, $720 | | Longevity physician (quarterly visits) | $1,200, $4,000 | | Advanced imaging (MRI, full-body) | $1,500, $3,000 | | APOE and pharmacogenomic testing | $400, $800 |

The Endocrine Society notes that "testosterone therapy in men without hypogonadism has not been shown to produce meaningful benefits and carries potential risks," a reminder that not every element of Attia's personal protocol applies to every patient [3].

What a Telehealth Patient Can Access Today

Several elements of Attia's protocol are now accessible through telehealth without a concierge medicine retainer. FDA-cleared OTC CGMs (Dexcom Stelo, Abbott Lingo) require no prescription [9]. Telehealth platforms can evaluate and manage TRT, thyroid optimization, and metabolic panels. Generic metformin remains one of the cheapest prescription drugs available.

Rapamycin for longevity requires a physician comfortable with off-label prescribing. A small but growing number of longevity-focused physicians will do this; the American Academy of Anti-Aging Medicine (A4M) maintains a provider directory, though board certification in longevity medicine is not yet standardized.

The single best investment by evidence-to-cost ratio remains cardiorespiratory fitness. Raising VO2max from the bottom quartile to the top half of age-adjusted norms is associated with a mortality risk reduction larger than any drug in this protocol [6].